L
Luis Almenar
Researcher at Instituto Politécnico Nacional
Publications - 230
Citations - 4276
Luis Almenar is an academic researcher from Instituto Politécnico Nacional. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 33, co-authored 222 publications receiving 3781 citations. Previous affiliations of Luis Almenar include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program.
Felipe Atienza,Manuel Anguita,Nieves Martínez-Alzamora,Joaquín Osca,Soledad Ojeda,Luis Almenar,Francisco Ridocci,Federico Vallés,José A. De Velasco +8 more
TL;DR: Disease management programs can reduce hospitalizations in high‐risk heart failure patients, but generalizability to the population hospitalized for HF remains to be proven.
Journal ArticleDOI
Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial
Michael Grimm,Mauro Rinaldi,Nizar Yonan,Giorgio Arpesella,J. M. Arizón Del Prado,Luis Alonso Pulpón,J. P. Villemot,Maria Frigerio,J. L. Rodriguez Lambert,Marisa G. Crespo-Leiro,Luis Almenar,D. Duveau,A. Ordonez-Fernandez,J. Gandjbakhch,M. Maccherini,Günther Laufer +15 more
TL;DR: Primary use of Tac during antibody induction resulted in superior prevention of acute rejection without an associated increase in infections, as was renal function.
Journal ArticleDOI
Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors
Marisa G. Crespo-Leiro,Luis Alonso-Pulpón,J.A. Vázquez de Prada,Luis Almenar,José M. Arizón,V. Brossa,Juan F. Delgado,Juan Fernández-Yáñez,Nicolás Manito,Gregorio Rábago,E. Lage,Eulalia Roig,Beatriz Díaz-Molina,D. Pascual,Javier Muñiz +14 more
TL;DR: The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003), and the influence of antiviral prophylaxis was investigated.
Journal ArticleDOI
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Josep Comín-Colet,Josep Comín-Colet,Nicolás Manito,Javier Segovia-Cubero,Juan F. Delgado,José Manuel García Pinilla,Luis Almenar,María G. Crespo-Leiro,Alessandro Sionis,T. Blasco,Domingo A. Pascual-Figal,Francisco González-Vílchez,José Luis Lambert-Rodríguez,María Grau,Jordi Bruguera,Lion-Heart Study Investigators +15 more
TL;DR: The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group, placebo‐controlled trial evaluating the efficacy and safety of intravenous administration of intermittent doses of levosimendan in outpatients with advanced chronic heart failure.
Journal ArticleDOI
Spanish Heart Transplantation Registry. 25th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013)
Francisco González-Vílchez,Manuel Gómez-Bueno,Luis Almenar,María G. Crespo-Leiro,José M. Arizón,Jesús Palomo,Juan F. Delgado,Eulalia Roig,E. Lage,Nicolás Manito +9 more
TL;DR: Cardiac transplantation activity in Spain has remained stable in recent years, at around 250 procedures per year, Despite a clear deterioration in donor and recipient characteristics and surgical times, the mortality outcomes have remained comparable to those of previous periods in the authors' environment.